| Literature DB >> 22455622 |
Chishih Chu1, Changyou Yu, Yanhaui Lee, Yaochi Su.
Abstract
BACKGROUND: Widespread in the environment, Staphylococcus spp. infect animals and humans as normal flora or pathogens. By extending our recent report of multi-drug resistant (MDR) S. aureus in dairy goats, this study investigated the staphylococcal infection and characterized the MDR-S. aureus and methicillin-resistant S. aureus (MRSA) isolates collected from goats in 2008 to elucidate the appearance of MRSA in goats and the mastitis associated staphylococcus enterotoxin (SE) types. A total of 555 samples were collected from six goat parts and three environmental sources among four dairy goat farms in southern Taiwan. Coagulase-positive and negative Staphylococcus spp. (CPS and CNS, respectively) were also identified. Furthermore, predominant SE genes of nine enterotoxin genes sea through sej along with antimicrobial resistance and genetic variations were determined.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22455622 PMCID: PMC3353860 DOI: 10.1186/1746-6148-8-39
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Prevalence of Staphylococcus spp. in different goat farms
| Sample site | Farm A (%) | Farm B (%) | Farm C (%) | Farm D (%) | Total | SA | CNSb | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SA | CNS | SA | CNS | SA | CNS | SA | CNS | ||||
| Dorsum | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Vagina | 10.0 | 10.0 | 9.5 | 19.0 | 15.0 | 25.0 | 18.2 | 45.5 | 34.7 | 6.6 | 12.4 |
| Anus | 0 | 20.0 | 0 | 38.1 | 0 | 45.0 | 0 | 45.5 | 36.1 | 0 | 19.0 |
| Udder | 0 | 15.0 | 0 | 9.5 | 5.0 | 5.0 | 0 | 9.1 | 11.1 | 0.7 | 5.1 |
| Nasal cavity | 35.0 | 0 | 9.5 | 9.5 | 5.0 | 10.0 | 18.2 | 36.4 | 27.8 | 8.8 | 5.8 |
| Milk | 2.5 | 20.0 | 2.4 | 33.3 | 2.5 | 42.5 | 4.3 | 52.2 | 37.9 | 2.9 | 39.4 |
| Apparatus | 0 | 6.7 | 0 | 0 | 0 | 0 | 0 | 0 | 2.9 | 0 | 0.7 |
| Bulk tank | 50.0 | 0 | 0 | 0 | 0 | 50.0 | 33.3 | 0.7 | 0.7 | ||
| Water | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6.8 | 11.2 | 3.1 | 18.9 | 4.0 | 23.3 | 5.9 | 31.8 | 24.7 | 19.7 | 80.3 |
a137 isolates consisted of 27 S. aureus isolates and 110 CNS isolates
bCNS: catalase-negative Staphylococcus spp
Susceptibility to 15 antimicrobials for Staphylococcus aureus isolated from the goat nasal cavity, vagina, and milk
| Antimicrobial | 2006-2007 | Location (2008) | |||
|---|---|---|---|---|---|
| Total | Goat milk | Nasal cavity | Vagina | ||
| Penicillin G | 57.0 | 85.2 | 50.0 | 100 | 88.9 |
| Ampicillin | 57.0 | 81.5 | 100 | 100 | 66.7 |
| Bacitracin | 0 | 29.6 | 0 | 50.0 | 22.2 |
| Cephalothin | 0 | 70.4 | 50 | 66.7 | 77.8 |
| Furoxime | 0 | 14.8 | 50.0 | 8.3 | 11.1 |
| Cloxacillin | 1.2 | 48.1 | 50.0 | 58.3 | 44.4 |
| Enrofloxacin | 2.3 | 0 | 0 | 0 | 0 |
| Gentamicin | 14.0 | 7.4 | 50.0 | 0 | 11.1 |
| Neomycin | 10.5 | 7.4 | 50.0 | 0 | 11.1 |
| Oxacillin | 0 | 40.7 | 50.0 | 58.3 | 33.3 |
| Oxytetracycline | 72.1 | 66.7 | 100 | 83.3 | 44.4 |
| Streptomycin | 22.1 | 40.7 | 50.0 | 41.7 | 44.4 |
| Tetracycline | 69.8 | 74.1 | 100 | 83.3 | 66.7 |
| Sulfamethoxazole/Trimethoprim | 2.3 | 7.4 | 50.0 | 8.3 | 0 |
Prevalence of enterotoxin genes in different Staphylococcus spp
| Enterotoxin genes | Positive rate (%) | |||
|---|---|---|---|---|
| Goat | Bovine | |||
| CNS (n = 71) | ||||
| 0 (0/113) | 0 (0/10) | 0 (0/71) | 11.1 (3/27) | |
| 0 (0/113) | 0 (0/10) | 0 (0/71) | 0 (0/27) | |
| 22.1 (25/113) | 80.0 (8/10) | 0 (0/71) | 0 (0/27) | |
| 0 (0/113) | 0 (0/10) | 0 (0/71) | 0 (0/27) | |
| 0.9 (1/113) | 0 (0/10) | 0 (0/71) | 0 (0/27) | |
| 0 (0/113) | 0 (0/10) | 0 (0/71) | 0 (0/27) | |
| 0 (0/113) | 0 (0/10) | 0 (0/71) | 0 (0/27) | |
| 0 (0/113) | 0 (0/10) | 0 (0/71) | 0 (0/27) | |
| 0 (0/113) | 0 (0/10) | 0 (0/71) | 0 (0/27) | |
a113 strains comprised 27 strains in 2008 and 86 strains in 2006-2007
b10 S. aureus strains isolated from 15 goat mastitis samples
c27 S. aureus strains isolated from cattle with mastitis
Characterization of 11 oxacillin-resistant S.aureus strains
| Strains | SCC | Pulsotypea | Farmsb | Pulsotype of human strainc | |
|---|---|---|---|---|---|
| N0119 | + | III | ND (ST59)d | A | |
| N0207 | + | III | ND (ST59) | A | |
| N0229 | + | III | I | A | A |
| N0262 | + | III | II | A | C |
| N6292 | + | III | III | A | A |
| N6294 | + | III | I | A | A |
| V34 | + | III | IV | A | D |
| V6292 | + | III | I | A | A |
| V17 | + | III | VIA | B | |
| N9 | + | II | VIB | B | |
| MR28 | + | II | V | D | A |
aND: DNA could not be digested by restriction enzyme SmaI
bLetters represent farms where samples were acquired
cPulsotypes were determined as previously reported by Huang et al. [22]
d ST determined based on the MLST website http://saureus.mlst.net/
Figure 1PFGE patterns of . Lanes 1, 4 and 7: pulsotype I; lane 2: pulsotype II, lane 3: pulsotype III, lane 5: pulsotype IV, lane 6: pulsotype V; lane 8: pulsotype VIA; and lane 9: pulsotype VIB. M: λ DNA marker.
Figure 2Phylogenetic tree of . The tree was constructed using the Megalign program of the Lasergene software. Scale bar represents number of nucleotide substitutions per? bases.
Primers used for amplification of SCCmec type and enterotoxin gene
| Locus | Primer | Oligonucleotide sequence (5'-3') | Amplicon size (bp) | SCC | Reference |
|---|---|---|---|---|---|
| SCC | |||||
| A | CIF2 F2 a | TTCGAGTTGCTGATGAAGAAGG | 495 | I | [ |
| CIF2 R2 a | ATTTACCACAAGGACTACCAGC | ||||
| B | KDP F1 b | AATCATCTGCCATTGGTGATGC | 284 | II | [ |
| KDP R1 b | CGAATGAAGTGAAAGAAAGTGG | ||||
| C | MECI P2 b | ATCAAGACTTGCATTCAGGC | 209 | II, III | |
| MECI P3 b | GCGGTTTCAATTCACTTGTC | ||||
| D | DCS F2a | CATCCTATGATAGCTTGGTC | 342 | I, II, IV | [ |
| DCS R1a | CTAAATCATAGCCATGACCG | ||||
| E | RIF4 F3c | GTGATTGTTCGAGATATGTGG | 243 | III | [ |
| RIF4 R9c | CGCTTTATCTGTATCTATCGC | ||||
| F | RIF5 F10c | TTCTTAAGTACACGCTGAATCG | 414 | III | |
| RIF5 R13c | GTCACAGTAATTCCATCAATGC | ||||
| G | IS431 P4b | CAGGTCTCTTCAGATCTACG | 381 | ||
| pUB110 R1b | GAGCCATAAACACCAATAGCC | ||||
| H | IS431 P4c | CAGGTCTCTTCAGATCTACG | 303 | ||
| pT181 R1c | GAAGAATGGGGAAAGCTTCAC | ||||
| MECA P4d | TCCAGATTACAACTTCACCAGG | 162 | Internal control | [ | |
| MECA P7d | CCACTTCATATCTTGTAACG | ||||
| Staphylococcal enterotoxin (SEs) | |||||
| ESA 1 | ACGATCAATTTTTACAGC | 544 | [ | ||
| ESA 2 | TGCATGTTTTCAGAGTTAATC | ||||
| ESB 1 | GAATGATATTAATTCGCATC | 416 | [ | ||
| ESB 2 | TCTTTGTCGTAAGATAAACTTC | ||||
| ESC 1 | GACATAAAAGCTAGGAATTT | 257 | [ | ||
| ESC 2 | AAATCGGATTAACATTATCCA | ||||
| ESD 1 | TTACTAGTTTGGTAATATCTCCTT | 334 | [ | ||
| ESD 2 | CCACCATAACAATTAATGC | ||||
| ESE 1 | ATAGATAAAGTTAAAACAAGCAA | 170 | [ | ||
| ESE 2 | TAACTTACCGTGGACCC | ||||
| ESG 1 | ACGTCTCCACCTGTTGAAGG | 400 | [ | ||
| ESG 2 | TGAGCCAGTGTCTTGCTTTG | ||||
| ESH 1 | TCACATCATATGCGAAAGCAG | 357 | [ | ||
| ESH 2 | TAGCACCAATCACCCTTTCC | ||||
| ESI 1 | TGGAACAGGACAAGCTGAAA | 467 | [ | ||
| ESI 2 | TAAAGTGGCCCCTCCATACA | ||||
| ESJ 1 | CAGCGATAGCAAAAATGAAACA | 426 | [ | ||
| ESJ 2 | TCTAGCGGAACAACAGTTCTGA | ||||
| setC-F | AGATTTAGCAAAGAAGTACAAAGATG | 490 | [ | ||
aRelative to accession no. AB033763, SCCmec type I
bRelative to accession no. D86934, SCCmec type II
cRelative to accession no. AB037671, SCCmec type III
dRelative to accession no. Y00688, mecA gene.
eLoci G and H were included to distinguish variants IA from I and IIIA from III, respectively
fPrimer pair used for PCR-RFLP